Last updated: March 22, 2025
The drug with NDC 62011-0310 is Allergy Relief, an over-the-counter (OTC) antihistamine containing diphenhydramine HCl (25 mg tablets) manufactured by Strategic Sourcing Services LLC under the Health Mart brand[14][15]. Below is a market analysis and price projection for this product:
Market Overview
The global diphenhydramine market (including OTC formulations like Allergy Relief) was valued at $1.5 billion in 2022 and is projected to reach $2.3 billion by 2030, growing at a CAGR of 6.5%[16]. Key drivers include:
- Rising allergy prevalence (50M+ affected annually in the U.S. alone)[16].
- Increasing self-medication trends, particularly for OTC allergy relief[16].
- Growing geriatric population susceptible to allergies and sleep disorders[16][20].
In the allergy treatment market, which includes diphenhydramine, the oral dosage segment dominates and is expected to grow at a 6.14% CAGR through 2033[13][19]. Retail pharmacies account for the largest distribution channel (e.g., Health Mart)[19].
Price Trends & Projections
-
Current Pricing:
- Diphenhydramine HCl API (active ingredient) prices in China reached $16,000/MT in Q2 2024[17].
- Finished OTC products like Allergy Relief typically retail for $0.03–$0.10 per tablet in bulk packaging[12][15].
-
Q1 2025 Forecast:
- Prices are projected to rise due to:
- Seasonal demand spikes (winter allergies/cold season)[18].
- Supply chain disruptions (Lunar New Year production halts in China)[18].
- Increased shipping costs (e.g., higher ocean freight rates)[18].
-
Long-Term Outlook (2030):
- Market expansion and raw material cost fluctuations will sustain a 5–7% annual price increase for OTC antihistamines[16][18].
Competitive Landscape
NDC 62011-0310 competes in the OTC allergy medication segment, which includes: |
Product |
Key Differentiator |
Market Share |
Allergy Relief (Health Mart) |
Retail pharmacy distribution[15] |
~8% (regional) |
Benadryl (Johnson & Johnson) |
Brand recognition |
~35% (U.S.)[20] |
Store-brand generics |
Lower pricing |
~50%[16] |
Health Mart’s strategic partnership with McKesson (Strategic Sourcing Services) provides supply chain advantages, but generic competition limits pricing power[14][16].
Risks & Opportunities
- Risks: Regulatory scrutiny of OTC sedatives, supply chain volatility[18].
- Opportunities: Expanding into emerging markets with high allergy prevalence (e.g., Asia-Pacific)[13][20].
Key Insight:
"Demand for OTC antihistamines is becoming less seasonal as climate change extends allergy periods globally"[13][18].
This analysis combines macro-industry trends with product-specific data, showing sustained growth with moderate price escalation for Allergy Relief (NDC 62011-0310) through 2030.
References
- https://www.ionos.co.uk/startupguide/grow-your-business/market-analysis-definition/
- https://www.findacode.com/ndc/labelers/Mckesson--62011
- https://www.accuweather.com/en/us/lake-norman-of-catawba/28673/weather-forecast/2621253
- https://www.industryarc.com/Report/15870/generic-drugs-market.html
- https://www.alooba.com/skills/concepts/marketing/market-analysis/
- https://www.drugs.com/relafen.html
- https://www.accuweather.com/en/us/lake-norman/28117/weather-forecast/2134211
- https://en.wikipedia.org/wiki/Market_analysis
- https://www.youtube.com/watch?v=cxkiprESYG8
- https://www.grandviewresearch.com/horizon/outlook/heat-pump-market-size/global
- https://ndclist.com/ndc/62011-0483/package/62011-0483-1
- https://www.drugpatentwatch.com/p/drug-price/drugname/index.php?query=ZOLPIDEM+TARTRATE
- https://www.globenewswire.com/news-release/2025/01/22/3013607/0/en/Allergy-Treatment-Market-Size-is-Projected-to-Reach-USD-64-65-billion-by-2033-Growing-at-a-CAGR-of-6-46-Straits-Research.html
- https://www.hipaaspace.com/medical_billing/coding/national.drug.codes/pdf/62011-0310-1
- https://www.hipaaspace.com/medical_billing/coding/national.drug.codes/62011-0310-1
- https://www.verifiedmarketreports.com/product/diphenhydramine-market/
- https://www.imarcgroup.com/diphenhydramine-hydrochloride-pricing-report
- https://www.chemanalyst.com/NewsAndDeals/NewsDetails/diphenhydramine-hydrochloride-prices-set-to-rise-in-q1-2025-amid-seasonal-demand-34237
- https://www.databridgemarketresearch.com/reports/global-allergy-treatment-market
- https://markwideresearch.com/global-diphenhydramine-market/